MANH MANH
Company Profile ↓Company Overview
MANH (MANH) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 69.9%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 73.0%.
Net profit has compounded at 17.5% per year over the last five years.
Maintains a net profit margin of 20.3%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $1.08B (+3.7% YoY); net profit $219.95M.
- Trailing 12 Months Year-on-year growth — revenue +3.8%, earnings +0.7%.
- 5-Year Trend Long-term compounding — revenue CAGR 9.7%, profit CAGR 17.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 9.68% |
| 1 Year: | 3.75% |
Compounded Profit Growth
| 5 Years: | 17.54% |
| 1 Year: | 0.73% |
Stock Price Performance
| 1 Year: | -12.11% |
| 6 Months: | +41.61% |
| 3 Months: | +36.08% |
| 1 Month: | +21.44% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)66.78 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 69.9%.
- Healthy ROCE of 73.0%.
- Excellent profit margin of 20.3%.
- Profit CAGR of 17.5% over 5 years.
- Generates positive free cash flow.
CONS
- Trading at a high P/E of 53.4.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | 143.49M | 154.14M | 152.88M | 144.09M | 130.57M | 141.87M | 142.35M | 144.37M | 148.40M | 154.34M | 162.28M | 152.93M | 153.90M | 135.63M | 149.76M | 147.08M | 156.85M | 166.11M | 169.19M | 178.96M | 191.92M | 198.10M | 221.01M | 231.02M | 238.44M | 254.55M | 265.32M | 266.68M | 262.79M | 272.42M | 275.80M | 282.21M | 297.79M |
| Operating Income | 41.37M | 43.68M | 39.53M | 43.10M | 52.27M | 53.58M | 45.36M | 41.72M | 49.26M | 51.10M | 43.57M | 27.83M | 35.69M | 36.10M | 34.28M | 28.28M | 27.58M | 35.00M | 25.07M | 24.20M | 26.69M | 34.98M | 28.20M | 25.43M | 39.36M | 42.41M | 33.97M | 37.25M | 36.77M | 47.09M | 50.48M | 53.45M | 57.63M | 68.19M | 75.09M | 63.17M | 73.79M | 75.83M | 64.94M | 66.23M |
| Net Income | 26.00M | 27.90M | 26.37M | 27.48M | 33.34M | 33.50M | 29.92M | 28.22M | 31.14M | 32.60M | 24.51M | 22.65M | 27.67M | 28.45M | 25.91M | 20.97M | 20.93M | 27.11M | 16.76M | 22.53M | 19.20M | 24.97M | 20.54M | 22.64M | 30.59M | 36.65M | 30.59M | 30.82M | 29.67M | 38.79M | 39.62M | 49.42M | 53.80M | 52.77M | 63.78M | 52.58M | 56.78M | 58.63M | 49.30M | 50.35M |
| Diluted EPS | 0.35 | 0.38 | 0.36 | 0.38 | 0.46 | 0.47 | 0.42 | 0.40 | 0.45 | 0.47 | 0.36 | 0.33 | 0.42 | 0.43 | 0.40 | 0.32 | 0.32 | 0.42 | 0.26 | 0.35 | 0.30 | 0.39 | 0.32 | 0.35 | 0.48 | 0.57 | 0.48 | 0.49 | 0.47 | 0.62 | 0.63 | 0.79 | 0.86 | 0.85 | 1.03 | 0.85 | 0.93 | 0.96 | 0.82 | 0.85 |
| R&D Expense | 13.26M | 13.59M | 13.46M | 14.71M | 13.46M | 13.39M | 13.18M | 14.22M | 14.10M | 14.75M | 14.63M | 17.06M | 18.18M | 18.45M | 18.21M | 21.21M | 22.00M | 22.61M | 21.78M | 23.33M | 19.93M | 20.45M | 20.56M | 24.26M | 23.21M | 23.37M | 27.45M | 27.92M | 29.38M | 30.79M | 31.60M | 33.09M | 35.01M | 35.33M | 34.35M | 35.30M | 34.87M | 36.36M | 37.35M | 34.77M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 246.67M | 297.12M | 90.70M | 104.40M | 110.80M | 134.60M | 131.30M | 604.56M | 594.60M | 559.16M | 617.95M | 586.37M | 663.64M | 767.08M | 928.73M | 1.04B | 1.08B |
| Operating Income | 21.14M | 41.93M | 61.36M | 80.07M | 101.29M | 127.12M | 161.45M | 194.31M | 185.65M | 133.89M | 115.92M | 114.06M | 134.33M | 152.70M | 209.88M | 261.60M | 279.80M |
| Net Income | 16.56M | 28.06M | 44.91M | 51.85M | 67.30M | 82.00M | 103.47M | 124.23M | 116.48M | 104.69M | 85.76M | 87.24M | 110.47M | 128.96M | 176.57M | 218.36M | 219.95M |
| Diluted EPS | 0.73 | 1.25 | 0.52 | 0.64 | 0.86 | 1.08 | 1.40 | 1.72 | 1.68 | 1.58 | 1.32 | 1.36 | 1.72 | 2.03 | 2.82 | 3.51 | 3.60 |
| R&D Expense | 36.68M | 40.51M | 42.37M | 44.70M | 44.55M | 48.95M | 53.86M | 54.74M | 57.70M | 71.90M | 87.61M | 84.28M | 97.63M | 111.88M | 126.81M | 137.69M | 145.06M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 280.46M | 259.60M | 261.81M | 297.83M | 318.17M | 332.24M | 297.14M | 315.00M | 307.15M | 372.28M | 465.41M | 539.71M | 570.18M | 673.35M | 757.55M | 839.39M |
| Total Equity | 179.84M | 183.37M | 183.80M | 162.08M | 161.51M | 181.59M | 182.02M | 195.49M | 169.37M | 174.96M | 147.15M | 142.28M | 218.90M | 250.64M | 226.80M | 278.28M | 299.13M | 314.76M |
| Cash & Equivalents | 85.74M | 120.22M | 120.74M | 92.18M | 96.74M | 124.38M | 115.71M | 118.42M | 95.61M | 125.52M | 99.13M | 110.68M | 204.71M | 263.71M | 225.46M | 270.74M | 266.23M | 328.75M |
| Current Liabilities | - | - | 86.38M | 88.12M | 91.14M | 104.19M | 122.81M | 127.19M | 117.64M | 124.25M | 145.26M | 181.60M | 196.99M | 249.04M | 315.60M | 365.92M | 400.30M | 455.91M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 58.32M | 49.97M | 55.82M | 75.27M | 89.39M | - | - | 139.35M | 164.07M | 137.35M | 146.91M | 140.88M | 185.18M | 179.63M | 246.22M | 295.00M | 389.47M |
| Investing Cash Flow | -2.29M | -8.88M | -4.61M | -7.01M | -7.80M | - | - | 3.36M | -5.77M | -9.84M | -13.75M | -2.73M | -4.02M | -6.59M | -4.73M | -8.68M | -15.46M |
| Financing Cash Flow | -21.71M | -40.86M | -77.95M | -63.54M | -51.81M | - | - | -162.70M | -131.71M | -149.32M | -121.49M | -43.56M | -120.42M | -204.46M | -196.05M | -286.37M | -315.16M |
| Capital Expenditure | -2.38M | -5.87M | -5.07M | -7.87M | -4.74M | -9.41M | -11.49M | -6.84M | -6.20M | -7.31M | -15.19M | -2.73M | -4.02M | -6.59M | -4.73M | -8.68M | -15.46M |
| Free Cash Flow | 55.95M | 44.10M | 50.75M | 67.40M | 84.65M | - | - | 132.50M | 157.87M | 130.04M | 131.72M | 138.16M | 181.17M | 173.04M | 241.49M | 286.33M | 374.01M |
| Share Buybacks | 23.43M | 77.70M | 133.14M | 103.16M | 64.20M | 99.20M | 112.14M | 167.93M | 131.71M | 149.32M | 121.49M | 43.56M | 120.42M | 204.46M | 196.05M | 286.37M | 315.16M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 8.6% | 14.1% | 67.7% | 76.7% | 91.4% | 94.4% | 123.0% | 32.1% | 31.2% | 23.9% | 18.8% | 19.5% | 20.2% | 19.9% | 22.6% | 25.1% | 25.9% |
| Net Margin % | 6.7% | 9.4% | 49.5% | 49.7% | 60.7% | 60.9% | 78.8% | 20.5% | 19.6% | 18.7% | 13.9% | 14.9% | 16.6% | 16.8% | 19.0% | 20.9% | 20.3% |
| ROE % | 9.0% | 15.3% | 27.7% | 32.1% | 37.1% | 45.0% | 52.9% | 73.4% | 66.6% | 71.1% | 60.3% | 39.9% | 44.1% | 56.9% | 63.5% | 73.0% | 69.9% |
| ROCE % | - | 21.6% | 35.8% | 46.9% | 52.3% | 65.1% | 78.7% | 108.3% | 97.3% | 82.7% | 60.8% | 42.5% | 46.2% | 60.0% | 68.3% | 73.2% | 73.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for MANH
Why Manhattan Associates (MANH) Stock Is Up Today - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxPNkdVYWk4Z0k3MlkwUzNIUlFhRU1JY1dILWRhZXlfbDJNM1FLMUgzdTNTa2xOQ0pmM2NqNmtna2tQQk1EclA3Ykcwa2gzSEhVd2VfdlAtY3oxbF8wMk12Y05Gc3UxZlVkLURmWnc5VERFWGRJcWttczljYUptUjJYMUd5QUxoSjJtbUpjZG…
3 Profitable Stocks We’re Skeptical Of - StockStory
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxQQVZSZG1Xam1aUXZWTTVRcUFTVmtDY1FoVjExMHRRbWJWNS1IdldRZUdKcXY4UXYwNkNZWXF3R1RnTmNCR3Z2OElDbUYwaGNJajhjNTJtTU5kS2piUHh3bjM3UEdGaE5ZaXNYVUptbjFYdS1jRkFaeTEzNml4X1hDbmtvcVplMlRHYkR2V0…
Have Manhattan Associates Insiders Been Selling Stock? - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxQb2IxZGhGdjAxY3VJUEQwYXk0MEw3UXVBS0NfMnZTZkxCQXQ5YUJfRVVSbVU1WGFVQUE3Zmg3Ym9qY21qMEM1SDQ3SkRINlN4NURJTWZfd1lmNWoydmtMOFZvSVprdlBHNHY1Q1FudXNLdVdzVmdLWG1BZzFidGp3WWs0aW9TUXNwRlNEcj…
Manhattan Associates (MANH) EVP sells 5,139 shares at $195.53 each - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxQNElLTnhjOHY1Z1c4bnZ6WU5lcUs3X2VXVG9xUF9UVnVvaHpVeHU4QnNfNnhmZk1wd1lmWXJvUy14amtsZFhTb1VOWmlfRzRyaHdndW9aekp4Tkt3TTFLSHFWNTl0UHEtYlFIVUpHak8yNmVkZzVhN0xXYnpINVhFcGU1cTZXdDYtRTZoUG…
Manhattan Associates, Inc. Stock 12‑Month Price Target Raised to $211.89, Implies 11% Upside - TradingView
<a href="https://news.google.com/rss/articles/CBMi4wFBVV95cUxQbjh4MnlvZ05SLW42ckN2V1pHUlRUSjI0YW5wdFJoYWloZlhrUG9VZzZERGl6NkVzd0pKSFBTcGgzTEZ0RTROaHRuTC1mQ3Bsd2dxX3BkMUEwdmd4bWVIVWVfdnhKcGYyS29DN0FCZDB4OXhfaEF5cnJkUHZxVDlyeV92Nk40cjNOMGZzSn…
Insider Selling: Manhattan Associates (NASDAQ:MANH) EVP Sells $1,004,828.67 in Stock - MarketBeat
<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxNMEg1SmVFR3VYNWJZVFVncXFfZUJHRktBUTl3RW1VRWxUbS1Zd1hFblVZTEliN1B3eUpTekJZaGgwdG40LTUzTjZlX2Q4V0U2ajlkMHh0aXIzZkh0SThpamxrWVJhYkxVd0FGVzgtS0xjT3pOUjJxQWVNVlpUVmVxaXp5SE9SLTFCZ09GWU…
MANH — Frequently Asked Questions
What is the current share price of MANH?
As of 2026-08-05 17:25 PDT, MANH trades at $192.08 on NASDAQ/NYSE. Its 52-week range is $120.88 to $220.19.
What is the P/E ratio of MANH?
MANH trades at a trailing price-to-earnings (P/E) ratio of 53.36.
What is the return on equity (ROE) of MANH?
MANH has a return on equity (ROE) of 69.88%. Its return on capital employed (ROCE) is 72.96%.
Is MANH a good stock to buy?
This page provides a data-driven analysis of MANH, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.